Invention Grant
- Patent Title: Anti-PDGF-C antibodies
-
Application No.: US14404052Application Date: 2013-04-24
-
Publication No.: US09884910B2Publication Date: 2018-02-06
- Inventor: Claudia Fromond , Hoa Thu Ngo , Richard Zwaal , Sofie Notebaert
- Applicant: ThromboGenics NV
- Applicant Address: BE Heverlee/Leuven
- Assignee: ThromboGenics NV
- Current Assignee: ThromboGenics NV
- Current Assignee Address: BE Heverlee/Leuven
- Agency: Fish & Richardson P.C.
- Priority: EP12165314 20120424; EP12192943 20121116
- International Application: PCT/EP2013/058513 WO 20130424
- International Announcement: WO2013/160359 WO 20131031
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/22 ; A61K39/00
Abstract:
The invention relates to antibodies binding to the PDGF-C antigen and capable of inhibiting binding of PDGF-C to the PDGFRα receptor and of inhibiting PDGFRα activation by PDGF-C. Applications of such antibodies are also disclosed. These include treatment of cancer.
Public/Granted literature
- US20150232546A1 ANTI-PDGF-C ANTIBODIES Public/Granted day:2015-08-20
Information query
